Pure Global AI
NCT06307080Recruiting

Clinical Study of Multi-mode Thermal Ablation for the Treatment of Pancreatic Cancer With Liver Metastasis

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Pancreatic Cancer
Drug/Device/Intervention
Multi-mode thermal ablation device
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
Oct 08, 2023
End date
Dec 31, 2024
Enrollment
12 participants
Primary outcome

Safety and efficacy assessment

Summary

1. Clinical evaluation of multimodal ablation system for pancreatic cancer with hepatic
 metastatic malignancies.
 
 2. Construction of a combined treatment system of multimodal ablation therapy combined with
 immunotherapy and chemotherapy.
 
 3. Transformation and clinical application of multimodal ablation system for pancreatic
 cancer with hepatic metastatic malignancies.

ICD-10 classifications
Malignant neoplasm of pancreasMalignant neoplasm: Pancreas, unspecifiedMalignant neoplasm: Head of pancreasMalignant neoplasm: Tail of pancreasMalignant neoplasm: Other parts of pancreas
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06307080
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06307080 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine and is currently Recruiting. The study focuses on Pancreatic Cancer. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.